Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022221
Filing Date
2017-11-07
Accepted
2017-11-07 16:06:18
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20170930.htm 10-Q 1181598
2 EX-31.1 rxdx-ex311_8.htm EX-31.1 18156
3 EX-31.2 rxdx-ex312_7.htm EX-31.2 17678
4 EX-32.1 rxdx-ex321_6.htm EX-32.1 6512
  Complete submission text file 0001564590-17-022221.txt   4824619

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxdx-20170930.xml EX-101.INS 1070210
6 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20170930.xsd EX-101.SCH 34325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20170930_cal.xml EX-101.CAL 38818
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20170930_def.xml EX-101.DEF 106192
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20170930_lab.xml EX-101.LAB 297321
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20170930_pre.xml EX-101.PRE 221522
Mailing Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

EIN.: 453174872 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36344 | Film No.: 171183405
SIC: 2834 Pharmaceutical Preparations